136 related articles for article (PubMed ID: 11464880)
1. Antiangiogenic therapy inhibits human neuroblastoma growth.
Katzenstein HM; Salwen HR; Nguyen NN; Meitar D; Cohn SL
Med Pediatr Oncol; 2001 Jan; 36(1):190-3. PubMed ID: 11464880
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden.
Katzenstein HM; Rademaker AW; Senger C; Salwen HR; Nguyen NN; Thorner PS; Litsas L; Cohn SL
Clin Cancer Res; 1999 Dec; 5(12):4273-8. PubMed ID: 10632370
[TBL] [Abstract][Full Text] [Related]
3. The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.
Shusterman S; Grupp SA; Barr R; Carpentieri D; Zhao H; Maris JM
Clin Cancer Res; 2001 Apr; 7(4):977-84. PubMed ID: 11309349
[TBL] [Abstract][Full Text] [Related]
4. CHS 828 inhibits neuroblastoma growth in mice alone and in combination with antiangiogenic drugs.
Svensson A; Bäckman U; Jonsson E; Larsson R; Christofferson R
Pediatr Res; 2002 May; 51(5):607-11. PubMed ID: 11978885
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470.
Shusterman S; Grupp SA; Maris JM
Med Pediatr Oncol; 2000 Dec; 35(6):673-6. PubMed ID: 11107144
[TBL] [Abstract][Full Text] [Related]
6. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma.
Nagabuchi E; VanderKolk WE; Une Y; Ziegler MM
J Pediatr Surg; 1997 Feb; 32(2):287-93. PubMed ID: 9044139
[TBL] [Abstract][Full Text] [Related]
7. Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapy.
Muramaki M; Miyake H; Hara I; Kamidono S
Clin Cancer Res; 2003 Nov; 9(14):5152-60. PubMed ID: 14613994
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of TNP-470 on hepatic metastasis of mouse neuroblastoma.
Yoshizawa J; Mizuno R; Yoshida T; Hara A; Ashizuka S; Kanai M; Kuwashima N; Kurobe M; Yamazaki Y
J Surg Res; 2000 Sep; 93(1):82-7. PubMed ID: 10945947
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis can be reduced without significant reduction of tumor growth.
Svensson A; Bäckman U; Fuchs D; Christofferson R; Azarbayjani F
Anticancer Res; 2007; 27(6B):3883-9. PubMed ID: 18225546
[TBL] [Abstract][Full Text] [Related]
10. The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis.
Bäckman U; Svensson A; Christofferson RH; Azarbayjani F
Anticancer Res; 2008; 28(3A):1551-7. PubMed ID: 18630510
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts.
Lund EL; Bastholm L; Kristjansen PE
Clin Cancer Res; 2000 Mar; 6(3):971-8. PubMed ID: 10741723
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
Gervaz P; Scholl B; Padrun V; Gillet M
Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
[TBL] [Abstract][Full Text] [Related]
13. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
[TBL] [Abstract][Full Text] [Related]
14. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.
Chesler L; Goldenberg DD; Seales IT; Satchi-Fainaro R; Grimmer M; Collins R; Struett C; Nguyen KN; Kim G; Tihan T; Bao Y; Brekken RA; Bergers G; Folkman J; Weiss WA
Cancer Res; 2007 Oct; 67(19):9435-42. PubMed ID: 17909053
[TBL] [Abstract][Full Text] [Related]
15. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
[TBL] [Abstract][Full Text] [Related]
16. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
[TBL] [Abstract][Full Text] [Related]
18. The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats.
Wassberg E; Påhlman S; Westlin JE; Christofferson R
Pediatr Res; 1997 Mar; 41(3):327-33. PubMed ID: 9078530
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma.
Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
Clin Cancer Res; 2003 Feb; 9(2):886-99. PubMed ID: 12576464
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effect of radiation response by combined treatment with angiogenesis inhibitor, TNP-470, in oral squamous cell carcinoma.
Shintani S; Li C; Mihara M; Klosek SK; Terakado N; Hino S; Hamakawa H
Oral Oncol; 2006 Jan; 42(1):66-72. PubMed ID: 16140034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]